东方生物

688298 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

4.5B ($655.9M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

828.0M

Net Income

-569.0M

Gross Margin

N/A

Op. Margin

-69.9%

Net Margin

-68.7%

ROE

-8.4%

ROA

-7.0%

D/E

0.19

Dividend Yield

N/A

EPS

-2.69

Current Ratio

3.30

Price History

Company Info

Industry	C27医药制造业
Market Segment	STAR Market
Currency	CNY
Fiscal Year	2024

Business Overview

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagnosis; and quantum-beads multiplex. Zhejiang Orient...

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 东方生物

Ticker	688298
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业